The overall burden of cancer is rapidly increasing worldwide, reflecting not only population
growth and aging, but also the prevalence and spread of risk factors. Gastrointestinal (GI) …

Background & Aims The highly proliferative nature of hepatocellular carcinoma (HCC)
frequently results in a hypoxic intratumoural microenvironment, which creates a therapeutic …

Background Gastrointestinal cancers account for a quarter of the global cancer incidence
and a third of cancer-related deaths. We sought to estimate the lifetime risks of developing …

Executive Summary Clinical Cancer Advances 2021: ASCO's Report on Progress Against
Cancer highlights the most important clinical research advances of the past year and …

Importance Immune checkpoint inhibitors (ICIs) are increasingly used in patients with
advanced hepatocellular carcinoma (HCC). However, data on ICI therapy in patients with …

Background The association between gastrointestinal cancer and types of meat
consumption, including red meat, processed meat, or a combination of both, remains …

Proteogenomic analyses of hepatocellular carcinomas (HCC) have focused on early-stage,
HBV-associated HCCs. Here we present an integrated proteogenomic analysis of HCCs …

Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus
statement from an international expert panel of International Society of Multidisciplinary …

Image-guided stimulus-responsive theranostics are beneficial for identifying malignant
lesions and integrating multiple cell-killing mechanisms to enhance tumor cell clearance …

Background Using data from the global burden of disease (GBD) between 1990 and 2019 to
report the leading etiological factors and hazards for liver cancer by HBV (LCHB), HCV …